Welcome back to our series of articles sponsored by Intel – “Ask a Data Scientist.” Once a week you’ll see reader submitted questions of varying levels of technical detail answered by a practicing ...

Compromised Outcomes in Stage IV Non–Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real-World Data I read the ...

Using observed imbalances between study groups (e.g., exposed and unexposed) to determine variables for confounding adjustment in nonrandomized studies may misguide the selection of variables to ...